Meroni, M.; Longo, M.; Paolini, E.; Alisi, A.; Miele, L.; De Caro, E.R.; Pisano, G.; Maggioni, M.; Soardo, G.; Valenti, L.V.;
et al. The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients. Cancers 2021, 13, 1783.
https://doi.org/10.3390/cancers13081783
AMA Style
Meroni M, Longo M, Paolini E, Alisi A, Miele L, De Caro ER, Pisano G, Maggioni M, Soardo G, Valenti LV,
et al. The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients. Cancers. 2021; 13(8):1783.
https://doi.org/10.3390/cancers13081783
Chicago/Turabian Style
Meroni, Marica, Miriam Longo, Erika Paolini, Anna Alisi, Luca Miele, Emilia Rita De Caro, Giuseppina Pisano, Marco Maggioni, Giorgio Soardo, Luca Vittorio Valenti,
and et al. 2021. "The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients" Cancers 13, no. 8: 1783.
https://doi.org/10.3390/cancers13081783
APA Style
Meroni, M., Longo, M., Paolini, E., Alisi, A., Miele, L., De Caro, E. R., Pisano, G., Maggioni, M., Soardo, G., Valenti, L. V., Fracanzani, A. L., & Dongiovanni, P.
(2021). The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients. Cancers, 13(8), 1783.
https://doi.org/10.3390/cancers13081783